Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407407
Status:
TERMINATED
Last Update Posted:
2019-10-18
First Post:
2006-12-01
Brief Title:
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian Primary Peritoneal or Fallopian Tube Carcinoma
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CA034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None